The depression drugs market, valued at over US$ 6.5 billion in 2017, is likely to witness bearishness in the near future, with a new report by Fact.MR estimating revenues to decline at a -2% CAGR. Click here to Get Complete
source https://www.openpr.com/news/2275154/atypical-antipsychotics-to-lead-global-depression-drugs-market